Hearing dogs for people with severe and profound hearing loss: a wait-list design randomised controlled trial investigating their effectiveness and cost-effectiveness

被引:4
|
作者
Stuttard, Lucy [1 ]
Boyle, Philip [1 ]
Fairhurst, Caroline [2 ]
Hewitt, Catherine [2 ]
Longo, Francesco [3 ]
Walker, Simon [3 ]
Weatherly, Helen [3 ]
Mayhew, Emese [1 ]
Beresford, Bryony [1 ]
机构
[1] Univ York, Dept Social Policy & Social Work, Social Policy Res Unit, Church Lane Bldg,York Sci Pk, Heslington YO10 5DF, England
[2] Univ York, York Trials Unit, York YO10 5DD, N Yorkshire, England
[3] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
关键词
GENERALIZED ANXIETY DISORDER; SERVICE DOGS; ADULTS; IMPAIRMENT; SCALE; DISABILITIES; WORK;
D O I
10.1186/s13063-021-05607-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Hearing loss increases the risk of poor outcomes across a range of life domains. Where hearing loss is severe or profound, audiological interventions and rehabilitation have limited impact. Hearing dogs offer an alternative, or additional, intervention. They live permanently with recipients, providing sound support and companionship. Methods: A single-centre, randomised controlled trial (RCT) evaluated the impacts of a hearing dog on mental well-being, anxiety, depression, problems associated with hearing loss (responding to sounds, fearfulness/social isolation), and perceived dependency on others. Participants were applicants to the UK charity `Hearing Dogs for Deaf People'. Eligibility criteria were as follows: first-time applicant; applying for a hearing dog (as opposed to other support provided by the charity). Participants were randomised 1:1 to the following: receive a hearing dog sooner than usual [HD], or within the usual application timeframe (wait-list [WL] comparator). The primary outcome was mental well-being (Short Warwick-Edinburgh Mental Well-Being Scale) 6 months (T1) after HD received a hearing dog. The cost-effectiveness analysis took a health and social care perspective. Results: In total, 165 participants were randomised (HD n = 83, WL n = 82). A total of 112 (67.9%) were included in the primary analysis (HD n = 55, WL n = 57). At T1, mental well-being was significantly higher in the HD arm (adjusted mean difference 2.53, 95% CI 1.27 to 3.79, p < 0.001). Significant improvements in anxiety, depression, functioning, fearfulness/social isolation, and perceived dependency, favouring the HD arm, were also observed. On average, HD participants had used fewer statutory health and social care resources. In a scenario whereby costs of provision were borne by the public sector, hearing dogs do not appear to be value for money. If the public sector made a partial contribution, it is possible that hearing dogs would be cost-effective from a public sector perspective. Conclusions: Hearing dogs appear to benefit recipients across a number of life domains, at least in the short term. Within the current funding model (costs entirely borne by the charity), hearing dogs are cost-effective from the public sector perspective. Whilst it would not be cost-effective to fully fund the provision of hearing dogs by the public sector, a partial contribution could be explored.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Effectiveness and cost-effectiveness of early assisted discharge for Chronic Obstructive Pulmonary Disease exacerbations: the design of a randomised controlled trial
    Cecile MA Utens
    Lucas MA Goossens
    Frank WJM Smeenk
    Onno CP van Schayck
    Walter van Litsenburg
    Annet Janssen
    Monique van Vliet
    Wiel Seezink
    Dirk RAJ Demunck
    Brigitte van de Pas
    Peter J de Bruijn
    Anouschka van der Pouw
    Jeroen MAM Retera
    Petra de Laat-Bierings
    Loes van Eijsden
    Maria Braken
    Riet Eijsermans
    Maureen PMH Rutten-van Mölken
    BMC Public Health, 10
  • [42] Effectiveness and cost-effectiveness of early assisted discharge for Chronic Obstructive Pulmonary Disease exacerbations: the design of a randomised controlled trial
    Utens, Cecile M. A.
    Goossens, Lucas M. A.
    Smeenk, Frank W. J. M.
    van Schayck, Onno C. P.
    van Litsenburg, Walter
    Janssen, Annet
    van Vliet, Monique
    Seezink, Wiel
    Demunck, Dirk R. A. J.
    van de Pas, Brigitte
    de Bruijn, Peter J.
    van der Pouw, Anouschka
    Retera, Jeroen M. A. M.
    de Laat-Bierings, Petra
    van Eijsden, Loes
    Braken, Maria
    Eijsermans, Riet
    Rutten-van Molken, Maureen P. M. H.
    BMC PUBLIC HEALTH, 2010, 10
  • [43] Effectiveness and Cost-Effectiveness of an Internet Based Cognitive Behavioural Psychotherapy for Depression: A Randomised Controlled Trial
    Hollinghurst, Sandra
    Kaur, Surinder
    Lewis, Glyn
    Peters, Tim
    Sharp, Debbie
    Wiles, Nicola
    Kessler, David
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S20 - S21
  • [44] The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
    Karen Morgan
    Mei-See Man
    Rachael Bloomer
    Madeleine Cochrane
    Melissa Cole
    Sandi Dheensa
    Nathan Eisenstadt
    Gene Feder
    Daisy M. Gaunt
    Rwth Leach
    Rebecca Kandiyali
    Sian Noble
    Tim J. Peters
    Beverly A. Shirkey
    Helen Cramer
    Trials, 24
  • [45] The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
    Morgan, Karen
    Man, Mei-See
    Bloomer, Rachael
    Cochrane, Madeleine
    Cole, Melissa
    Dheensa, Sandi
    Eisenstadt, Nathan
    Feder, Gene
    Gaunt, Daisy M.
    Leach, Rwth
    Kandiyali, Rebecca
    Noble, Sian
    Peters, Tim J.
    Shirkey, Beverly A.
    Cramer, Helen
    TRIALS, 2023, 24 (01)
  • [46] The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trial
    Howard, Robert
    Gathercole, Rebecca
    Bradley, Rosie
    Harper, Emma
    Davis, Lucy
    Pank, Lynn
    Lam, Natalie
    Talbot, Emma
    Hooper, Emma
    Winson, Rachel
    Scutt, Bethany
    Montano, Victoria Ordonez
    Nunn, Samantha
    Lavelle, Grace
    Bateman, Andrew
    Bentham, Peter
    Burns, Alistair
    Dunk, Barbara
    Forsyth, Kirsty
    Fox, Chris
    Poland, Fiona
    Leroi, Iracema
    Newman, Stanton
    O'Brien, John
    Henderson, Catherine
    Knapp, Martin
    Woolham, John
    Gray, Richard
    AGE AND AGEING, 2021, 50 (03) : 882 - 890
  • [47] Investigating the cost-effectiveness of videotelephone based support for newly diagnosed paediatric oncology patients and their families: design of a randomised controlled trial
    Mark Bensink
    Richard Wootton
    Helen Irving
    Andrew Hallahan
    Deborah Theodoros
    Trevor Russell
    Paul Scuffham
    Adrian G Barnett
    BMC Health Services Research, 7
  • [48] Investigating the cost-effectiveness of videotelephone based support for newly diagnosed paediatric oncology patients and their families: design of a randomised controlled trial
    Bensink, Mark
    Wootton, Richard
    Irving, Helen
    Hallahan, Andrew
    Theodoros, Deborah
    Russell, Trevor
    Scuffham, Paul
    Barnett, Adrian G.
    BMC HEALTH SERVICES RESEARCH, 2007, 7 (1)
  • [49] Effectiveness and cost-effectiveness of humanistic counselling in schools for young people with emotional distress (ETHOS): study protocol for a randomised controlled trial
    Stafford, Megan Rose
    Cooper, Mick
    Barkham, Michael
    Beecham, Jeni
    Bower, Peter
    Cromarty, Karen
    Fugard, Andrew J. B.
    Jackson, Charlie
    Pearce, Peter
    Ryder, Rebekah
    Street, Cathy
    TRIALS, 2018, 19
  • [50] Parkinson's disease REHAB: Randomised controlled trial to study the effectiveness and cost-effectiveness of physiotherapy and occupational therapy for people with PD
    Dowling, F. P.
    Rick, C.
    Sackley, C.
    Ives, N.
    Patel, S.
    Yao, G. L.
    Wheatley, K.
    Clarke, C. E.
    MOVEMENT DISORDERS, 2012, 27 : S115 - S115